Tested Applications
| Positive WB detected in | A549 cells, HeLa cells, SGC-7901 cells |
| Positive IHC detected in | mouse kidney tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | MDCK cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
14844-1-AP targets Myh9 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, canine samples.
| Tested Reactivity | human, mouse, canine |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | myosin, heavy polypeptide 9, non-muscle |
| Calculated Molecular Weight | 226 kDa |
| Observed Molecular Weight | 224 kDa |
| GenBank Accession Number | NM_022410 |
| Gene Symbol | Myh9 |
| Gene ID (NCBI) | 17886 |
| RRID | AB_2147311 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8VDD5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MYH9, also named as NMMHC-A and NMMHC-IIA, is a cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. It plays an important role in cytoskeleton reorganization, focal contacts formation (in the margins but not the central part of spreading cells), and lamellipodial retraction, during cell spreading.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for Myh9 antibody 14844-1-AP | Download protocol |
| IHC protocol for Myh9 antibody 14844-1-AP | Download protocol |
| WB protocol for Myh9 antibody 14844-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Myh9 Polyclonal antibody (Cat# 14844-1-AP) has 14 citations published in journals including Nature Communications, Molecular Cancer, Theranostics, Scientific Reports, Cells, Biomolecules, Cell Cycle, Neuromolecular Medicine, Biomedical Pharmacotherapy, Journal of Neuroscience Research, Clinical Genetics, International Journal of Clinical and Experimental Pathology, Noncoding RNA Research, and Journal of Clinical Biochemistry and Nutrition. Research fields span intestinal metaplasia, colitis, craniofacial development, blood-brain barrier integrity, breast cancer, diabetic kidney disease, congenital diaphragmatic hernia, cochlear biology, anorectal malformations, hepatocellular carcinoma, and protein glycation.
| Species | Application | Title |
|---|---|---|
Mol Cancer OLFM4 promotes the progression of intestinal metaplasia through activation of the MYH9/GSK3β/β-catenin pathway | ||
Nat Commun The non-muscle-myosin-II heavy chain Myh9 mediates colitis-induced epithelium injury by restricting Lgr5+ stem cells. | ||
Theranostics Trio cooperates with Myh9 to regulate neural crest-derived craniofacial development.
| ||
Cells Endothelial Myosin IIA Is Required for the Maintenance of Blood-Brain Barrier Integrity | ||
Biomolecules Lipopolysaccharide Stimulates A549 Cell Migration through p-Tyr 42 RhoA and Phospholipase D1 Activity | ||
Noncoding RNA Res LncRNA MEG3/CTCF-CXCR4 axis functions in the regulation of breast cancer cell migration |







